vimarsana.com
Home
Live Updates
Assertio Holdings, Inc. Announces the Acquisition of Otrexup
Assertio Holdings, Inc. Announces the Acquisition of Otrexup
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Related Keywords
United States ,
Max Nemmers ,
Dan Peisert ,
Company Nasdaq ,
Assertio Holdings Inc ,
Nasdaq ,
Teva Pharmaceutical Industries Ltd ,
Exchange Commission ,
Pfizer ,
Pfizer Inc ,
Antares Pharma ,
Securities Exchange ,
Idorsia Pharmaceuticals Ltd ,
Antares Pharma Inc ,
Zyla Life Sciences The Merger ,
Reported Revenues ,
Otrexup Were ,
Pay Antares ,
Full Year Net Product Sales ,
Chief Executive Officer ,
Product Sales ,
Expire Orange Book Listed ,
Revenue Ended ,
Teva Pharmaceutical Industries ,
Idorsia Pharmaceuticals ,
Sumatriptan Injection ,
Investor Relations ,
Securities Act ,
Securities Exchange Act ,
Zyla Life Sciences ,
United States Securities ,
Annual Report ,
Quarterly Reports ,
Technology ,
Business ,
Health ,
Globe Newswire ,